Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes

Song,De-Wei; Xin,Nian; Xie,Bing-Jie; Li,Yu-Juan; Meng,Ling-Yan; Li,Hong-Mei; Schläppi,Michael; Deng,Yu-Lin

doi:10.3892/ijmm.2013.1604

Formation of a salsolinol-like compound, the neurotoxin, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, in a cellular model of hyperglycemia and a rat model of diabetes

Authors:
- De-Wei Song
- Nian Xin
- Bing-Jie Xie
- Yu-Juan Li
- Ling-Yan Meng
- Hong-Mei Li
- Michael Schläppi
- Yu-Lin Deng
View Affiliations

Affiliations: Division of Chemical Metrology and Analytical Science, National Institute of Metrology, Beijing 100013, P.R. China, School of Life Science, Beijing Institute of Technology, Beijing 100081, P.R. China, Marquette University, Milwaukee, WI 53233, USA
Published online on: December 24, 2013 https://doi.org/10.3892/ijmm.2013.1604
Pages: 736-742

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There are statistical data indicating that diabetes is a risk factor for Parkinson's disease (PD). Methylglyoxal (MG), a biologically reactive byproduct of glucose metabolism, the levels of which have been shown to be increase in diabetes, reacts with dopamine to form 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ); this formation may provide further insight into the connection between PD and diabetes. In this study, we investigated the role of ADTIQ in these two diseases to determine in an aim to enhance our understanding of the link between PD and diabetes. To this end, a cell model of hyperglycemia and a rat model of diabetes were established. In the cell model of hyperglycemia, compared with the control group, the elevated glucose levels promoted free hydroxyl radical formation (p<0.01). An ADTIQ assay was successfully developed and ADTIQ levels were detected and quantified. The levels of its precursors, MG and dopamine (DA), were determined in both the cell model of hyperglycemia and the rat model of diabetes. The proteins related to glucose metabolism were also assayed. Compared with the control group, ADTIQ and MG levels were significantly elevated not only in the cell model of hyperglycemia, but also in the brains of rats with diabetes (p<0.01). Seven key enzymes from the glycolytic pathway were found to be significantly more abundant in the brains of rats with diabetes. Moreover, it was found that adenosine triphosphate (ATP) synthase and superoxide dismutase (SOD) expression levels were markedly decreased in the rats with diabetes compared with the control group. Therefore, ADTIQ expression levels were found to be elevated under hyperglycemic conditions. The results reported herein demonstrate that ADTIQ, which is derived from MG, the levels of which areincreased in diabetes, may serve as a neurotoxin to dopaminergic neurons, eventually leading to PD.

View Figures

View References

1	Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A and Chen H: Diabetes and Risk of Parkinson’s Disease. Diabetes Care. 34:910–915. 2011.
2	Schernhammer E, Hansen J, Rugbjerg K, Wermuth L and Ritz B: Diabetes and the risk of developing Parkinson’s disease in Denmark. Diabetes Care. 34:1102–1108. 2011.
3	Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA and Bennett DA: Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology. 63:996–1001. 2004. View Article : Google Scholar : PubMed/NCBI
4	Deng YL, Zhang YQ, Li YJ, Xiao SY, Song DW, Qing H, Li Q and Rajput AH: Occurrence and distribution of salsolinol-like compound, 1-acetyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (ADTIQ) in parkinsonian brains. J Neural Transm. 119:435–441. 2012. View Article : Google Scholar : PubMed/NCBI
5	Ristow M: Neurodegenerative disorders associated with diabetes mellitus. J Mol Med (Berl). 82:510–529. 2004. View Article : Google Scholar : PubMed/NCBI
6	Deng YL and Rajput AM: 126th Annual Meeting, American Neurological Association: Abstracts: Plenary Session: Epilepsy. Ann Neurol. 50(Suppl 1): S19–S22. 2001. View Article : Google Scholar
7	Haik GM Jr, Lo TW and Thornalley PJ: Methylglyoxal concentration and glyoxalase activities in the human lens. Exp Eye Res. 59:497–500. 1994. View Article : Google Scholar : PubMed/NCBI
8	Zhu W, Wang D, Zheng J, An Y, Wang Q, Zhang W, Jin L, Gao H and Lin L: Effect of (R)-salsolinol and N-methyl-(R)-salsolinol on the balance impairment between dopamine and acetylcholine in rat brain: involvement in pathogenesis of Parkinson disease. Clin Chem. 54:705–712. 2008. View Article : Google Scholar : PubMed/NCBI
9	Zhang Y, Xiao S, Wang L, Wang H, Zhu Y, Li Y and Deng Y: Absolute quantification of semicarbazide-sensitive amine oxidase in human umbilical artery by single-reaction monitoring with electrospray tandem mass spectrometry. Anal Bioanal Chem. 397:709–715. 2010. View Article : Google Scholar
10	Wang R, Qing H, Liu XQ, Zheng XL and Deng YL: Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells. Neurosci Bull. 24:125–132. 2008. View Article : Google Scholar : PubMed/NCBI
11	Song DW, Du HQ, Wang L, Hu GF and Deng YL: Analysis of catechol quinoline substance in corpus striatum and hippocampus from brains of diabetic rat models by HPLC-MS. Chemistry. 11:1049–1052. 2010.
12	Song DW, Hu GF, Zhou Y, Wang HB, Wang L, Zhu Y and Deng YL: Proteomic analysis of proteins related to Parkinson’s disease in the corpus striatum and hippocampus of diabetes rat model. Chemistry. 6:430–434. 2008.
13	Kuhla B, Loske C, Garcia De Arriba S, Schinzel R, Huber J and Münch G: Differential effects of ‘Advanced glycation endproducts’ and beta-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y. J Neural Transm. 11:427–439. 2004.
14	Emdadul Haque M, Asanuma M, Higashi Y, Miyazaki I, Tanaka K and Ogawa N: Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells. Biochim Biophys Acta. 1619:39–52. 2003.PubMed/NCBI
15	Collins MO, Yu L, Coba MP, Husi H, Campuzano I, Blackstock WP, Choudhary JS and Grant SGN: Proteomic analysis of in vivo phosphorylated synaptic proteins. J Biol Chem. 280:5972–5982. 2005. View Article : Google Scholar : PubMed/NCBI
16	Song DW, Li Q, Luan YJ, Niu LY, Qing H and Deng YL: Comparative proteomic analysis of neural stem cells between differentiating and undifferentiating to dopaminergic neuron. Complex Medical Engineering (CME). In: IEEE/ICME International Conference, 1817–1823; 2007
17	Diez L, Livertoux MH, Stark AA, Wellman-Rousseau M and Leroy P: High-performance liquid chromatographic assay of hydroxyl free radical using salicylic acid hydroxylation during in vitro experiments involving thiols. J Chromatogr B Biomed Sci Appl. 763:185–193. 2001. View Article : Google Scholar
18	Ferger B, Spratt C, Earl CD, Teismann P, Oertel WH and Kuschinsky K: Effects of nicotine on hydroxyl free radical formation in vitro and on MPTP-induced neurotoxicity in vivo. Naunyn Schmiedebergs Arch Pharmacol. 358:351–359. 1998. View Article : Google Scholar : PubMed/NCBI
19	Copeland RL Jr, Das JR, Kanaan YM, Taylor RE and Tizabi Y: Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res. 12:61–69. 2007. View Article : Google Scholar : PubMed/NCBI
20	Yi H, Maruyama W, Akao Y, Takahashi T, Iwasa K, Youdim MB and Naoi M: N-Propargylamine protects SH-SY5Y cells from apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, through stabilization of mitochondrial membrane and induction of anti-apoptotic Bcl-2. J Neural Transm. 113:21–32. 2006. View Article : Google Scholar
21	Maruyama W, Akao Y, Youdim MB, Davis BA and Naoi M: Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. J Neurochem. 78:727–735. 2001. View Article : Google Scholar
22	Wanpen S, Kooncumchoo P, Shavali S, Govitrapong P and Ebadi M: Salsolinol, an endogenous neurotoxin, activates JNK and NF-kappaB signaling pathways in human neuroblastoma cells. Neurochem Res. 32:443–450. 2007. View Article : Google Scholar : PubMed/NCBI
23	Kheradpezhouh M, Shavali S and Ebadi M: Salsolinol causing parkinsonism activates endoplasmic reticulum-stress signaling pathways in human dopaminergic SK-N-SH cells. Neurosignals. 12:315–324. 2003. View Article : Google Scholar
24	Thornalley PJ, Jahan I and Ng R: Suppression of the accumulation of triosephosphates and increased formation of methylglyoxal in human red blood cells during hyperglycaemia by thiamine in vitro. J Biochem. 129:543–549. 2001. View Article : Google Scholar : PubMed/NCBI
25	Dmitriev LF and Dugin SF: Aldehydes and disturbance of carbohydrate metabolism: some consequences and possible approaches to its normalization. Arch Physiol Biochem. 113:87–95. 2007. View Article : Google Scholar : PubMed/NCBI
26	Sheu KF, Ho HT, Nolan LD, Markovitz P, Richard JP, Utter MF and Frey PA: Stereochemical course of thiophosphoryl group transfer catalyzed by mitochondrial phosphoenolpyruvate carboxykinase. Biochemistry. 23:1779–1783. 1984. View Article : Google Scholar
27	Richard JP: Mechanism for the formation of methylglyoxal from triosephosphates. Biochem Soc Trans. 21:549–553. 1993.PubMed/NCBI
28	Han YC, Randell E, Vasdev S, Gill V, Gadag V, Newhook LA, Grant M and Hagerty D: Plasma methylglyoxal and glyoxal are elevated and related to early membrane alteration in young, complication-free patients with Type 1 diabetes. Mol Cell Biochem. 305:123–131. 2007. View Article : Google Scholar : PubMed/NCBI
29	MacDonald MJ, Chaplen FWR, Triplett CK, Gong Q and Drought H: Stimulation of insulin release by glyceraldehyde may not be similar to glucose. Arch Biochem Biophys. 447:118–126. 2006. View Article : Google Scholar : PubMed/NCBI
30	Caccese D, Pratico D, Ghiselli A, Natoli S, Pignatelli P, Sanguigni V, Luliano L and Violi F: Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation - role of arachidonic acid metabolism. Thromb Haemost. 83:485–490. 2000.PubMed/NCBI
31	Shi HL and Liu KJ: Effects of glucose concentration on redox status in rat primary cortical neurons under hypoxia. Neurosci Lett. 410:57–61. 2006. View Article : Google Scholar : PubMed/NCBI
32	Adam W, Kurz A and Saha-Möller CR: Peroxidase-catalyzed oxidative damage of DNA and 2′-deoxyguanosine by model compounds of lipid hydroperoxides: involvement of peroxyl radicals. Chem Res Toxicol. 13:1199–1207. 2000.
33	Hong JH, Kim MJ, Park MR, Kwag OG, Lee IS, Byun BH, Lee SC, Lee KB and Rhee SJ: Effects of vitamin E on oxidative stress and membrane fluidity in brain of streptozotocin-induced diabetic rats. Clin Chim Acta. 340:107–115. 2004. View Article : Google Scholar : PubMed/NCBI
34	Sima AAF and Li ZG: The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes. 54:1497–1505. 2005. View Article : Google Scholar : PubMed/NCBI
35	Stevens MJ, Zhang W, Li F and Sima AA: C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats. Am J Physiol Endocrinol Metab. 287:E497–E505. 2004. View Article : Google Scholar : PubMed/NCBI